Challenges of building a new vaccine delivery platform for LMICs
|
|
- Ruth Mitchell
- 5 years ago
- Views:
Transcription
1 Challenges of building a new vaccine delivery platform for LMICs Terri B. Hyde, MD MPH Immunizations Systems Branch, GID, CDC 23 March 2017 Immunization in the Elderly Geneva, Switzerland
2 What has been the experience of vaccination platform development initiatives in ages beyond infancy (HPV, MCV2)? Are there generalizable lessons learned for a new vaccine platform contexts in LMICs?
3 Expanded Program on Immunization (EPI) Launched by WHO in 1974 with a standard immunization schedule of 6 basic antigens for infants Vaccine Recommended Age of Vaccination Birth 6 weeks 10 weeks 14 weeks 9 months BCG X OPV X X x DTP X X X Measles X DTP Diptheria Tetanus Pertussis BCG Bacillus Calmette-Guerin
4 2016 EPI Schedule in Ghana Vaccine Birth 6 wks Recommended age of vaccination mths 9 mths wks wks 12 mths BCG X OPV X X X X Rotavirus X X PCV X X X DPT/HepB/Hib X X X IPV (Q3 2016) X Measles/Rubella* X X Yellow Fever X Men A (Q3 2016) X Vitamin A supplement X X X ITN distribution X *MCV2 introduced 2012; changed to MR mths
5 No. of reported cases Millions Annual reported measles cases and MCV1/2 coverage ( ) Campaigns Measles incidence in 2015: 36 / million down by 75% since 2000 Target: < 5 / million MCV1 MCV MCV Coverage* (%) Number of cases MCV1 Coverage* MCV2 Coverage* * Coverage as estimated by WHO and UNICEF. **MCV2 estimates is only available from 2000 when global data collection started, however some countries have introduced the vaccine earlier. Source: JRF 194 WHO Member States. Updated on 18 July 2016
6 Steady Progress with MCV2, % 61% Source: WHO/UNICEF coverage estimates 2015 revision. July 2016 and WHO database as at 25 July 2016 Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 25 July 2016.
7 Ghana 2YL Project Overview 5 year project CDC, Ghana Health Services, WHO, UNICEF 3. Social Mobilization & demand generation 4. Program Integration Multi-faceted approach to strengthening the second year of life 2. Data recording & reporting 5. VPD Surveillance Address issues in 6 Key Strategic areas 1. Training & Supervision Stronger Second Year of Life 6. Special innovations
8 Findings and Activities 1) Training and Supervision Source Situational analysis Baseline survey Finding Minimal MCV2 and 2YL specific training during introduction Reference materials for health care workers had no 2YL specific content Vague catch-up policy Reports of batching children for MR and/or MCV Received EPI training >1 year ago or did not remember 54-80% Responded one dose MCV was sufficient to protect against measles disease 18-40% Responded it was more important to immunize children <12m vs 12-23m 40-45% Would give MCV (not MR) to 18mo missing first dose measles 20-48% Year Activity 2016 Interpersonal communication training, Job aides 2017 Training (pre-service, in-service, new hire); focus 2YL & adult learning, Regional and District Health Teams
9 Findings and Activities 2) Data Recording & Reporting Source Situational analysis Baseline survey Year Finding New tally sheets and registers included MCV2 but confusion on how to record doses Lack of strategies to track children into the 2YL Electronic registries compatible with DHIS2 planned in some districts Prepared written list of defaulters 15-23% For scenario of 18mo receiving first dose of MCV: Recorded dose incorrectly in tally sheet (MCV1 0-11m or MCV m) 26-50% Recorded dose incorrectly as MCV2 in register 17-42% Told caregiver to return in 1 month for second dose 79-85% Cards reviewed had MCV2 return date indicated 1-9% Activity 2016 Child health record books, EPI data dictionaries, Vaccine reporting & management books 2017 Training on defaulter tracing, recording doses; Evaluation of etracker (DHIS2) and SMS
10 Findings and Activities 3) Demand and Social Mobilization Source Situational analysis Finding General trust in the EPI system for infant antigens Predominant norm that routine immunization services end at 9 months of age Cultural perception that children are not at risk once they begin to walk Minimal demand creation during MCV2 introduction: one radio message Baseline survey Year Had heard of a vaccine against measles 68-75% Did not know of age for either MCV1 or MCV % Children who went to growth monitoring at 18m and did not receive MCV2 7-24% Reported easier to bring 9mo to clinic than 18mo 52-54% HCW was most trusted source of information Activity about immunization 51-97% 2016 Television and radio blasts, Posters YL specific communications materials for HF staff and caregivers, 5 key messages
11 Findings and Activities 4) Program Integration Source Situational analysis Baseline survey Finding EPI integrated with growth monitoring, nutrition, deworming and bednet distribution in most areas Up to 70% of children enrolled in daycare or crèches by age 3, particularly in Accra School health program disconnected with EPI Child cared for by another adult during the day 7-29% 12-23mo 16-35% 24-35mo Caregivers receptive to child being immunized in daycare or crèche % Workload: 2YL increased the number of sessions held 56-74% Workload: 2YL increased the time to hold those sessions 55-64% Year Activity 2016 Pilot workshop with daycare/crèche proprietors in Greater Accra 2017 Daycare/crèche proprietor workshops across all 3 regions
12 HPV vaccine introduction to date ,000 women developed cervical cancer, 270,000 died. 85% in LICs /MICs 2013 GAVI Support for HPV vaccine introduction Initially required evidence of ability to reach adolescent girls with high coverage as it was a new platform, 2 year demonstration projects funded < 5% age cohort of girls fully immunized 2016 (March), 70 countries had introduced HPV vaccine, mainly in limited demonstration settings Slow move towards national introduction in low and middle income countries 2017 Gavi guidelines aim to accelerate national introduction National introduction (phased introduction optional) Support for multi-age cohort (9-14 years) in first year Followed by single age cohort (e.g. 9 years) in subsequent years
13 Study by numbers Data from 46 countries (18 LIC, 22 LMIC, 5 UMIC, 1 HIC): 12 national introductions. 66 demonstration projects. 92 distinct delivery experiences. 120 years of cumulative vaccination experience. >1,750,000 girls reached. >1,400,000 girls fully vaccinated. Ninety-two distinct delivery experiences: defined by the vaccination venue and target population within a specific project/programme. Countries Projects/ programmes Delivery experiences Countries with demonstration projects or national programmes: 46 Demonstration project experience only: demonstration projects, defined by donor and implementer Demonstration project experience + 1 year of national rollout: 10 National rollout without demonstration project: 2 12 national programmes 1 year 77 delivery experiences 15 delivery experiences 92 delivery experiences 1 1Data was received from three countries planning to scale up to national rollout from their demonstration project in and four other programmes which had planned to change delivery strategy in
14 Planning and coordination Findings Lack of political commitment created delays in vaccine importation and funds disbursement. Lack of initial involvement by health and education sectors created difficulties in planning and implementation. Lack of strong involvement by the national immunisation programme caused problems with systems, transportation, and human resources. Weak supervision of training created challenges; resulted in inadequate knowledge transfer. Insufficient time for planning posed a challenge to implementation. Lessons learnt Lack of political commitment early in the process caused delays later in the programme. Failure to coordinate early with national immunisation programme staff, MOE, and MOF led to planning, social mobilisation, and delivery problems. Not allowing enough time for planning led to poor decision-making, lack of availability of funds, and untimely disbursement. 49
15 Communication and social mobilisation Findings Gaps in communications training for school staff, teachers, and community leaders allowed rumours to take hold when questions could not be answered. Some countries underestimated the power of negative media exposure, including social media. Several countries faced challenges with HPV vaccine acceptance in private schools if they were not engaged early in social mobilisation. Lessons learnt Not engaging, or engaging too late, with local community leaders derailed social mobilisation efforts in some cases. Insufficient training of school staff/teachers and lack of a crisis communications plan perpetuated rumours. Failure to engage sufficiently or early enough with private schools led to resistance by school leaders and parents. 50
16 Delivery Findings Specific strategies are needed to reach out-of-school girls and those without them often saw low coverage in this group. Strategies that did not clearly define, implement, or train health workers on eligibility criteria faced challenges in enumeration and calculation of coverage. Lessons learnt Limited focus on strategies to deliver HPV vaccine to out-of-school girls led to low coverage in that group. Failure to understand and implement eligibility criteria during enumeration and vaccine delivery created difficulties estimating coverage. PATH/Le Thi Nga
17 Lessons from 2YL and adolescent vaccination Political commitment and early engagement of national immunization program is important to success New platforms involve behavior change in individuals, caregivers, and health staff New vaccine delivery sites require close coordination, planning, and delivery with all entities involved in vaccination and the new sites National immunization programme, schools, ministry of education, ministry of finance New vaccine strategies may be needed to reach the entire population Simplify logistics to access care Children may be in school in 2YL, parents working In school vs out of school girls The least complicated delivery strategy is best Vaccine safety Understanding concerns of health staff and caregivers Communication and training to address concerns and rumors in communities
18 Challenges in developing a new vaccine platform No current uniform platform to deliver vaccine to adult and elderly populations Wide scale roll-out limited without global recommendation/ financial support Public policy recommendation (SAGE), GAVI support for vaccine Strong political commitment needed for successful implementation Mobilization of financial and human resources needed to achieve program goal Adequately funded programs, health care worker workload Where does the target population receive health care Match vaccine delivery sites to population Assess need for alternate delivery strategies, defaulter tracing Is there a reliable denominator of target population to estimate needs Adequate demand creation among target population and health care workers Social mobilization and behavior change to request vaccine
19 Opportunities in developing a new vaccine platform New vaccine platforms provide the opportunity to reach elimination goals, provide catch-up vaccination, booster doses, new vaccines, other preventive services Countries are already gaining experience in reaching new populations beyond infancy Areas identified to improve performance of the new vaccine platforms are similar in both the second year of life and adolescent platforms, and strategies to address these are being tested
Mobilize, Deliver, Sustain: Lessons learnt and practical advice for effective HPV vaccine delivery in low- and middle-income countries
Mobilize, Deliver, Sustain: Lessons learnt and practical advice for effective HPV vaccine delivery in low- and middle-income countries Deborah Watson-Jones, Katherine Gallagher, Carol Tevi-Benissan and
More informationGlobal landscape analysis and literature review of 2 nd Year of Life immunization platform
Global landscape analysis and literature review of 2 nd Year of Life immunization platform Global Vaccine and Immunization Research Forum 15-17 March 2016 Johannesburg, South Africa Imran Mirza; Celina
More informationImplementing HPV Vaccine: A Review of Seven Key Themes for Decision-makers
HPV Vaccine Lessons Learnt Implementing HPV Vaccine: A Review of Seven Key Themes for Decision-makers Jane Doe Title, Organization Day Month, 2015 PATH/David Jacobs Study objectives 1. Collate and synthesize
More informationAfghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision
Afghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data
More informationHarnessing the power of vaccines using the public and private sector: A 21 st century model for international development
Harnessing the power of vaccines using the public and private sector: A 21 st century model for international development Dr. Seth Berkley, CEO GAVI Alliance Wellcome Trust Cambridge Centre for Global
More informationGovernment of Bangladesh
Gavi Full Country Evaluations Findings Summary of recommendations Expanded Programme on Immunization Government of Gavi Secretariat With country-level partners, target efforts on low coverage areas and
More informationEstablishing a second-year-of-life (2YL) healthy child visit
Establishing a second-year-of-life (2YL) healthy child visit Dr Rudi Eggers Presentation to the Global Vaccines and Immunization Research Forum Sandton, 15 March 2016 Session Objectives Provide an overview
More informationHPV Vaccine Lessons Learned & New Ways Forward
HPV Vaccine Lessons Learned & New Ways Forward The Gavi Alliance June 2016, Geneva www.gavi.org Overview 1 Background 2 Lessons learned 3 New Way Forward 2 1 Background 3 HPV Background HPV is responsible
More informationTowards the Achievement of GHSA 2024 s Overarching Targets
정보화파트업무계획 [GHSA] Immunization Towards the Achievement of GHSA 2024 s Overarching Targets 2016년추진업무및 2017년업무계획 ( 사업관리 ) 7 th November 2018 Korea Centers for Disease Control and Prevention I. Overview Contents
More informationAccess to vaccination in GAVI countries and at global level
Access to vaccination in GAVI countries and at global level Stefano Malvolti Director, Vaccine Implementation GAVI Alliance 15th ADVANCED COURSE OF VACCINOLOGY May 12, 2014 Global progress to MDG 4 for
More informationExpanded Programme on Immunization (EPI)
Bhutan 2017 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles containing
More informationused for HPV vaccine delivery to identify best practices and inform efforts to improve HPV vaccine coverage nationwide.
Gavi Full Country Evaluations Findings Summary of recommendations Ministry of Finance» Be involved at all stages of planning for new vaccine introductions. Ministry of Health» Conduct a survey to fully
More informationThe Johns Hopkins Vaccine Initiative Johns Hopkins Bloomberg School of Public Health
WHO Internships (Terms of Reference) for VIEW Scholars Program January 2010 A. Examining approaches to collecting and analyzing HPV vaccine coverage data B. County level burden of disease estimates for
More informationVERSION APPROVAL PROCESS NUMBER 1.0 Nina Schwalbe, Managing Director, Policy and Performance
Version No.: 1.0 Page 1 / 5 DOCUMENT ADMINISTRATION VERSION APPROVAL PROCESS DATE NUMBER 1.0 Nina Schwalbe, Managing Director, and Performance Reviewed by: GAVI Programme 23 April 2012 and Committee Approved
More informationDr. Collins Tabu 24 th April 2018 Nairobi, Kenya
Dr. Collins Tabu 24 th April 2018 Nairobi, Kenya Immunization in the developing world Every year, millions of children in poor countries die from preventable diseases because they do not have access to
More informationNigeria: WHO and UNICEF estimates of immunization coverage: 2017 revision
Nigeria: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received
More informationExpanded Programme on Immunization (EPI)
Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationSustainable Development Goals (SDGs) Immunization indicator selection
Sustainable Development Goals (SDGs) Immunization indicator selection SAGE Oct. 2017 18 October 2017 Pr. Narendra Arora SDG 2030 agenda is deliberately ambitious and transformational at its heart is a
More informationProgress reports on selected Regional Committee resolutions:
REGIONAL COMMITTEE Provisional Agenda item 4.7.2 Sixty-sixth Session SEA/RC66/14 SEARO, New Delhi, India 10 13 September 2013 19 July 2013 Progress reports on selected Regional Committee resolutions: 2012:
More informationThe Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007
History & Future of the Expanded Programme on Immunization Supplier Meeting, Copenhagen, 3-4 April 2008 Dr Osman David Mansoor Senior Adviser EPI (New Vaccines) UNICEF New York The Gates Challenge If we
More informationMCSP Mozambique Program Brief Strengthening Immunization Services
MCSP Mozambique Program Brief Strengthening Immunization Services November 2018 www.mcsprogram.org Goal The Maternal and Child Survival Program (MCSP) in Mozambique used the Reaching Every District/Reaching
More informationPakistan: WHO and UNICEF estimates of immunization coverage: 2017 revision
Pakistan: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received
More informationVaccine Hesitancy: Acceptance and demand of vaccines in the Americas
Vaccine Hesitancy: Acceptance and demand of vaccines in the Americas Desiree Pastor, MD, MPH Regional Immunization Advisor Immunization Unit Department of Family, Gender and Life Course PAHO/WHO Outline
More informationExpanded Programme on Immunization (EPI)
Sri Lanka 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationGavi s private sector engagement approach
Gavi s 2016-2020 private sector engagement approach SCALING INNOVATION FOR IMPACT Gavi Board technical briefing session 21 June 2016 Geneva, Switzerland Reaching further, together www.gavi.org A HISTORY
More informationHPV vaccine: a critical component in a comprehensive cervical cancer prevention program
HPV vaccine: a critical component in a comprehensive cervical cancer prevention program Vivien Tsu UICC World Cancer Congress Montreal, August 27-30, 2012 Background on cervical cancer Incidence highest
More informationGavi initiatives for improving vaccine supply
Gavi initiatives for improving vaccine supply Melissa Malhame DCVMN, 28 October 2014 A world free from vaccine preventable diseases www.gavi.org Agenda 1. Gavi Strategy 2011-2015, and supply and procurement
More informationExpanded Programme on Immunization (EPI)
Indonesia 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationUpdate on Implementation of NUV. Carsten Mantel WHO/FCH/IVB/EPI
Update on Implementation of NUV Carsten Mantel WHO/FCH/IVB/EPI Introduction of New Vaccines The continuum of activity REGULATORY NORMS & STANDARDS VACCINE SUPPLY PROCUREMENT PRICING FINANCING SURVEILLANCE
More informationGavi s strategic framework 22 June 2016
Gavi s 2016 2020 strategic framework 22 June 2016 Gavi 2000-2015 Gavi 3.0 Gavi 2.0 250 million children immunised Gavi 1.0 90m children immunised 200 million children immunised 2000 2005 2006 2010 2011
More informationUpdate from the GAVI Alliance Seth Berkley, MD Chief Executive Officer
Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer SAGE meeting Geneva, 8-10 November 2011 Topics to cover Update on new vaccine introduction Introductions New approvals Co-financing
More informationAddendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG)
Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG) Background India was certified polio-free along with 10 other countries of WHO South-East Asia Region
More informationTODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE
TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE Aurélia Nguyen Tuesday 20 January 2015, Veyrier-du-Lac, France www.gavi.org AGENDA Market
More informationReport to the. GAVI Alliance Board June 2013
Report to the GAVI Alliance Board 11-12 June 2013 Subject: Report of: Authored by: Risk Management Update Helen Evans, Deputy CEO Ciara Goldstein, Analyst, Performance Management and Adrien de Chaisemartin,
More informationJohns Hopkins Vaccine Initiative 2013 Vaccine Internship Experience at WHO (VIEW) Sample Internship Descriptions
Johns Hopkins Vaccine Initiative 2013 Vaccine Internship Experience at WHO (VIEW) Sample Internship Descriptions A. Launching of Updated Malaria Vaccine Technology Roadmap & Associated Activities... 2
More informationGavi Secretariat Update: Progress, priorities and strategies
Gavi Secretariat Update: Progress, priorities and strategies Melissa Malhame UNICEF Vaccine Manufacturer Consultation Copenhagen 8-9 October 2014 www.gavi.org Gavi s impact 2000-2013 2 New vaccines now
More informationPLANNING & EVALUATION WORKBOOK
25 April-2 May 2015 PLANNING & EVALUATION WORKBOOK WEB: www.paho.org/vwa FACEBOOK: https://www.facebook.com/pahowho TWITTER: https://twitter.com/pahowho VWA 2015 PLANNING INTRODUCTION Originally launched
More informationPLANNING & EVALUATION WORKBOOK. WEB: FACEBOOK:
PLANNING & EVALUATION WORKBOOK WEB: www.paho.org/vwa FACEBOOK: https://www.facebook.com/paho.im TWITTER: http://twitter.com/opspaho_vac INTRODUCTION Originally launched in 2003, Vaccination Week in the
More informationGavi, the Vaccine Alliance - Health System and Immunisation Strengthening (HSIS) Support Framework
Gavi, the Vaccine Alliance - Health System and Immunisation Strengthening (HSIS) Support Framework I. Purpose This Framework sets out the principles and several essential requirements for Gavi s Health
More informationThe power of partnership: the GAVI Alliance Board
The power of partnership: the GAVI Alliance Board 1 GAVI s mission To save children s lives and protect people s health by increasing access to immunisation in poor countries Strategic goals 2011 2015!
More informationCLOSING MR IMMUNITY GAPS EXPERIENCES FROM THE REGIONS MALAWI. Geoffrey Zimkambani Chirwa EPI Manager
CLOSING MR IMMUNITY GAPS EXPERIENCES FROM THE REGIONS MALAWI Geoffrey Zimkambani Chirwa EPI Manager Outline (1) Background of the NIP and epidemiology of MR How did you diagnose that older teenager/adult
More informationTable 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.
EPI history EPI launched in 978 with DPT, OPV, BCG and typhoid vaccines TT immunization of pregnant women introduced in 983 MCV introduced in 985 HepB piloted in 00 and made universal in 0 MCV introduced
More informationDr. Collins Tabu KPA Conference, 26 th April 2018 Mombasa, Kenya
Dr. Collins Tabu KPA Conference, 26 th April 2018 Mombasa, Kenya Presentation Outline Background Immunization Performance review Available Opportunities for engagement Planned and ongoing strategies- New
More informationHPV Demonstration Programme Update and initial lessons learnt on programme design. HPV Subteam Geneva, Switzerland June 17, 2014
HPV Demonstration Programme Update and initial lessons learnt on programme design HPV Subteam Geneva, Switzerland June 17, 2014 Most recent data on cervical cancer shows higher mortality in less developed
More informationGAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS
GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS Ranjana Kumar International Rotavirus Symposium Istanbul, 3 4 June 2008 The GAVI Alliance Public-private partnership bringing
More informationTable 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)
EPI history EPI started in 978 EPI re-structured in March 000 DTP-HepB vaccine introduced in 007 DTP-Hib-HepB)vaccine introduced in 0 MR vaccine introduced in Feb 06 Second dose of MR introduced in Feb
More informationGAVI, THE VACCINE ALLIANCE
#vaccineswork GAVI, THE VACCINE ALLIANCE Natasha Bilimoria December 2016 National Academy of Sciences www.gavi.org 1 ABOUT GAVI Gavi s mission: to save children s lives and protect people s health by increasing
More informationGlobal Health Policy: Vaccines
Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY
More informationSimplifying pediatric immunization with a fully liquid pentavalent vaccine: Evidence from a time-motion study
Simplifying pediatric immunization with a fully liquid pentavalent vaccine: Evidence from a time-motion study Dr. Karin Anne Wiedenmayer Swiss Tropical Institute Basel, Switzerland February 2008 1 Value
More informationTargeted Diseases and Immunization. Strategic plan
Targeted Diseases and Immunization Strategic plan 2008-2013 Communicable Diseases Unit WHO Regional Office for Europe Mission To provide technical support to WHO European Region Member States to ensure
More informationExercise: Estimating immunization program costs (~60 minutes)
Exercise: Estimating immunization program costs (~60 minutes) Overview Information on the cost of procuring vaccines and of running national immunization program is a key factor in planning and managing
More informationwithin three to six months of the launch of a new vaccine.
Gavi Full Country Evaluations Findings Summary of recommendations General Provide short and succinct reference materials for new vaccines to health workers rather than wait for the National Immunization
More informationPolio and routine immunisation Alan Brooks
Polio and routine immunisation Alan Brooks Geneva, Switzerland, Background 1 History of polio eradication World Health Assembly Resolution 400 Previous eradication targets Polio cases (thousands) 300 200
More informationTable 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210
EPI history EPI launched in 980 HepB vaccine introduced in 003 AD syringes introduced in 003 HepB birth dose introduced in 004 DTP-HepB vaccine introduced in 006 MCV introduced in 008 DTP-Hib-HepB vaccine
More informationReport to the Board 6-7 June 2018
Report to the Board 6-7 June 2018 SUBJECT: Category: PROGRAMME AND POLICY COMMITTEE CHAIR REPORT For Information Section A: Introduction This report provides the Board with an overview of the activities
More informationUNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013
UNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013 Presentation overview Scope of UNICEF procurement Overview of UNICEF procurement Vaccine market updates UNICEF procures
More informationTable 1: Basic information 2017
EPI history EPI launched in 978 OPV and MCV introduced in 987 AD syringes introduced in 00 HepB vaccine introduced in 003 MCV introduced partially in 008 and made available nationwide in 0 DTP-Hib-HepB
More informationExpanded Programme on Immunization
Expanded Programme on Immunization Expanded Programme on Immunization has been implementing the reduction of morbidity and mortality due to vaccine preventable diseases among the children aged 1 to 5 years
More informationDownloaded from:
Gallagher, KE; Kabakama, S; Howard, N; Mounier-Jack, S; Griffiths, UK; Feletto, M; Lamontagne, DS; Burchett, HED; Watson-Jones, D (2016) Lessons learnt from human papillomavirus (HPV) vaccine demonstration
More informationMidterm Review of the Global Measles and Rubella Strategic Plan W. A. Orenstein, MD SAGE Geneva, 19 October 2016
Midterm Review of the Global Measles and Rubella Strategic Plan 2012 2020 W. A. Orenstein, MD SAGE Geneva, 19 October 2016 1 Outline Strategic Plan 2012-2020 Progress toward milestones and goals Objectives
More informationSummary of Definitions of Mission and Strategic Goal Level Indicators. in GAVI Alliance Strategy Updated October 2013
Summary of s of Mission and Strategic Goal Level Indicators in GAVI Alliance Strategy 2011-2015 Updated October 2013 Table of Contents Under five mortality rate ------------------------------------------------------------------------------------------------------------------------
More informationGavi Alliance Strategy : Goal level indicators and disease dashboard
Gavi Alliance Strategy 2016-2020: Goal level indicators and disease dashboard BOARD MEETING Peter Hansen and Hope Johnson 10-11 June 2015, Geneva Reach every child www.gavi.org Strategic enablers Goal-level
More informationVaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines
Vaccine Innovation: Challenges and Opportunities to Protect Health Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines Protecting Health with Vaccines HEALTH IMPROVEMENT Population Impact Guidelines
More informationObjective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch
Objective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch Polio Partners Group meeting Geneva 8 December 2014 Michel Zaffran Coordinator, WHO/EPI, IMG Co-chair On behalf
More informationIntroduction of the Second Dose of Measles Containing Vaccine in the Childhood Vaccination Programs Within the WHO Africa Region Lessons Learnt
the Second Dose of Measles Containing Vaccine in the Childhood Vaccination Programs Within the WHO Africa Region Lessons Learnt. J Immunol Sci (2018); S Research Article Open Access Introduction of the
More informationResponding to the SAGE Recommendations on Middle Income Countries Since Sarah Schmitt WHO Consultant
Responding to the SAGE Recommendations on Middle Income Countries Since 2010 Sarah Schmitt WHO Consultant 1 Plan SAGE Recommendation Expanding on the Identification of Issues WHO & Partners: Regional and
More informationPolio and measles control: opportunities and threats for health systems
Polio and measles control: opportunities and threats for health systems USAID Global Health Mini University March 4, 2016 Dr. Craig Burgess, JSI OVERVIEW Polio and measles: an overview Control strategies
More informationParadigm shift: from dependency to country ownership Seth Berkley, MD Chief Executive Officer of the GAVI Alliance
Paradigm shift: from dependency to country ownership Seth Berkley, MD Chief Executive Officer of the GAVI Alliance Sabin 20 th Anniversary Scientific Forum 25 April 2014 The GAVI Alliance: a public-private
More informationUpdate on Transition: the case of Honduras. Minister Dra Yolani Batres AMRO/EURO Gavi Constituency Representative Geneva June 2016
Update on Transition: the case of Honduras Minister Dra Yolani Batres AMRO/EURO Gavi Constituency Representative Geneva June 2016 GAVI Support for Honduras Content Honduras EPI Situation 2011-2016 Vaccination
More informationAn aggressive approach for measles outbreak among adolescents in Barranquilla, Colombia, 2011
Closing immunity gaps in older children and adults towards measles and rubella elimination: Lessons learned and challenges. Siena, Italy, May 10-11 2016 An aggressive approach for measles outbreak among
More informationMARKET UPDATE: ROUTINE VACCINE INTRODUCTIONS PCV HPV ROTA
UNICEF/UN074388/LeMoyne MARKET UPDATE: ROUTINE VACCINE INTRODUCTIONS PCV HPV ROTA Vaccine Industry Consultation October 2018 Pneumococcal Conjugate Vaccine (PCV) Background The AMC initiative has opened
More informationIMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION. GAVI Board - 13 June 2017, Geneva
IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION GAVI Board - 13 June 2017, Geneva SCALE OF HUMANITARIAN RESPONSE NEEDS Strengthened HC System Improved financing Cluster Approach HUMANITARIAN
More informationAgenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 1 3 April 2014 CCV/CICG, Geneva
Version: 14 March 2014 Agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 1 3 April 2014 CCV/CICG, Geneva Tuesday, 1 April 2014 Time Session Purpose of session, target outcomes
More informationOVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE
OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE Dr Tiong Wei Wei, MD, MPH Senior Assistant Director Policy and Control Branch, Communicable Diseases Division Ministry of Health 9
More informationGOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights
GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION (indicator G2.2) Highlights As of December 2014, 140 Member States had introduced rubella vaccines; coverage, however, varies from 12% to 94% depending on region.
More informationIMMUNISATION CHALLENGES IN FIJI AND THE PACIFIC. 10th New Zealand Immunization Conference Litiana Volavola, National EPI Programme Officer, Fiji
IMMUNISATION CHALLENGES IN FIJI AND THE PACIFIC 10th New Zealand Immunization Conference Litiana Volavola, National EPI Programme Officer, Fiji Fiji: facts and figures Total population: 905,776 Total live
More informationEnsuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments
Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments Introduction While polio exists anywhere, countries with low
More informationTotal population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000
India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written
More informationPrinciples and considerations for adding a vaccine into a national immunization programme
Principles and considerations for adding a vaccine into a national immunization programme From decision to implementation Excerpted sections for the April 2012 SAGE session: Impact of vaccine introductions
More informationBack to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office
Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office SAGE, Geneva 27 October 2009 Rebecca Martin Targeted Diseases and
More informationVaccine Hesitancy: an international perspective
Vaccine Hesitancy: an international perspective Brickset.com Noni MacDonald 1, Sarah Lane 2, Melanie Marti 3 1. Dept Pediatrics, Dalhousie University, Canadian Centre for Vaccinology, Halifax, Canada 2.
More informationUpdate on Periodic Intensification of Routine Immunization (PIRI)
Update on Periodic Intensification of Routine Immunization (PIRI) Presented by: Adolphus T. Clarke Deputy Programme Manager Expanded Programme on Immunization (EPI)/MOH January 30, 2015 Presentation Structure
More informationImmunization Update & focus on meningococcal vaccine PART 1
Immunization Update & focus on meningococcal vaccine PART 1 Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases University of Cape Town www.vacfa.uct.ac.za Disclosures Received
More informationVaccines. Global impact of a preventive technology. Edwin J. Asturias, MD
Vaccines Global impact of a preventive technology Edwin J. Asturias, MD Associate Professor of Pediatrics and Epidemiology Director for Latin America Center for Global Health, Colorado School of Public
More informationPLANNING WORKBOOK 11 th Vaccination Week in the Americas
PLANNING WORKBOOK 11 th Vaccination Week in the Americas 2013 slogan: Vaccination: a shared responsibility WEB: www.paho.org/vwa FACEBOOK: https://www.facebook.com/paho.im TWITTER: http://twitter.com/opspaho_vac
More informationYear: 2017 Volume:5 Issue-1 Introduction of newer vaccines in Immunization Programme of India: Challenges to be addressed
Editorial Year: 2017 Volume:5 Issue-1 Introduction of newer vaccines in Immunization Programme of India: Challenges to be addressed Dr. Samir Dasgupta1 1 Professor & Head, Department of Community Medicine,
More informationAnnex 7a. Evaluation of routine second dose measles vaccination (health facility based implementation)
Annexes Annex 7a. Evaluation of routine second dose measles vaccination (health facility based implementation) Appendix 1.1: Questionnaire Central/regional/district Date of interview.... Name of interviewer....
More informationEMRO May (EMVAP) Action
EMRO Framework for implementation Global Vaccine May Eastern Mediterr ranean Vaccine Action Plan 2016-2020 (EMVAP) A Framework for Implementation of Global Vaccine Action Plan (GVAP) Eastern Mediterranean
More informationGAVI Role in IPV Introductions
GAVI Role in IPV Introductions Melissa Malhame 12 th WHO/UNICEF Consultation with OPV/IPV Manufacturers and National Regulatory Authorities Geneva, Switzerland, 10 GAVI vaccine support Currently supported
More informationANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for immunization programme managers
ANALYSIS AND USE OF HEALTH FACILITY DATA Guidance for immunization programme managers WORKING DOCUMENT FEBRUARY 2018 World Health Organization 2018 All rights reserved. This is a working document and should
More informationReport. 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria
Report 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria Kano, Nigeria 12-13 July 2006 Executive Summary The 10 th Expert Review Committee (ERC) met in Kano on 12-13 July
More informationThailand Expanded Program on Immunization. Suchada Jiamsiri, MD, MPH Division of Vaccine Preventable Diseases Ministry of Public Health, Thailand
Thailand Expanded Program on Immunization Suchada Jiamsiri, MD, MPH Division of Vaccine Preventable Diseases Ministry of Public Health, Thailand Outline Expanded Program on Immunization Organization Immunization
More informationMeasles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012
Measles Containing Vaccines UNICEF Supply Division Industry Consultation Meeting 25-26 January 2012 Content Measles monovalent vaccine: Programme Updates and Procurement Overview Measles and Rubella vaccine:
More informationEstablishing and strengthening immunization in the second year of life. Practices for vaccination beyond infancy
Establishing and strengthening immunization in the second year of life Practices for vaccination beyond infancy Establishing and strengthening immunization in the second year of life: practices for vaccination
More informationReport from the Pertussis Working Group
Report from the Pertussis Working Group Elizabeth Miller SAGE Member and Chair of the Pertussis Working Group 29 October 2009 Geneva Working Group Members Elizabeth Miller (chair), Health Protection Agency,
More informationTotal population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594
Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%
More information6. Making a comprehensive annual national immunization plan and budget
L=D$>K7$%-#%+ ORIGINAL : ENGLISH Training for mid-level managers (MLM) 6. Making a comprehensive annual national immunization plan and budget Analyse data Interactive problemsolving Combine and Check completeness
More informationSelected vaccine introduction status into routine immunization
Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF
More informationPLANNING & EVALUATION WORKBOOK 26 April-3 May 2014
PLANNING & EVALUATION WORKBOOK 26 April-3 May 2014 WEB: www.paho.org/vwa FACEBOOK: https://www.facebook.com/paho.im TWITTER: http://twitter.com/opspaho_vac INTRODUCTION Originally launched in 2003, Vaccination
More information